An observational study in Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones:a New Method by, sponsored by Yingxin FU.MD. Enrolling by invitation at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-07-19.
Sponsored by Yingxin FU.MD · Observational
we report the manual manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys with Renal Stones,including nine cases,Renal transplantation was performed with the treated kidney after removing the stones, and the short-term postoperative outcomes were promising. cases were thoroughly reported in this paper.
The presence of donor kidney stones may lead to ureteral obstruction after transplantation, affecting the recovery of postoperative renal function. Thus, donors with kidney stones are often considered marginal kidney donors and likely disqualified,Here we describe a series case of multiple kidney stones in a donor kidney treated with the combined application of fURS and holmium laser lithotripsy (HLL) before transplantation. Renal transplantation was performed with the treated kidney after removing the stones, and the short-term postoperative outcomes were promising. The case was thoroughly reported in this paper.
598 studies on the registry are indexed under Kidney Calculi; 163 are open to participants now.
This study's planned enrollment of 9 is below the median of 144 across 110 observational studies indexed under Kidney Calculi.
Browse Kidney Calculi studies →This is the only study on the registry with Yingxin FU.MD as lead sponsor.
Counted across the registry records on this site, refreshed daily.
patinet in our centor get a ranal transplantation with stones
Exclusion Criteria:
eGFR
renal function
Time frame: 3monthes after transplantation
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.